Charles River Laboratories CRL Redeemable noncontrolling interests in subsidiaries
Redeemable noncontrolling interests in subsidiaries at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's redeemable noncontrolling interests in subsidiaries.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's redeemable noncontrolling interests in subsidiaries?
- Charles River Laboratories (CRL) reported redeemable noncontrolling interests in subsidiaries of $41.9M in Q1 2026.
- How has Charles River Laboratories's redeemable noncontrolling interests in subsidiaries changed year-over-year?
- Charles River Laboratories's redeemable noncontrolling interests in subsidiaries increased by 0.6% year-over-year, from $41.66M to $41.9M.
- What is the long-term trend for Charles River Laboratories's redeemable noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Charles River Laboratories's redeemable noncontrolling interests in subsidiaries has grown at a 10.1% compound annual growth rate (CAGR), from $25.5M to $41.26M.
- What does redeemable noncontrolling interests in subsidiaries mean?
- This represents the portion of equity in a subsidiary that is held by third parties but includes a redemption feature that allows the holder to force the company to buy back the interest. Because of the redemption feature, these interests are often classified outside of permanent equity. It highlights potential future cash outflows required to settle these minority stakes.